They aren't just "pandemic stocks." ...

ALBANY, NY (News10) – Six years ago this month, New York declared a state of emergency due to covid-19. With the pandemic, the use of mRNA technology for vaccines became more mainstream. At UAlbany, ...

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Researchers developed DoriVac, a DNA origami-based vaccine platform that precisely arranges antigens and adjuvants to enhance ...

Reuters Antitrust Correspondent Jody Godoy interviews FTC Bureau of Competition Director Daniel Guarnera at Reuters Pharma USA this week in Philadelphia. With patent cliffs approaching and plenty of ...

The US Centers for Disease Control and Prevention's vaccine advisory committee has postponed a decision regarding future recommendations for mRNA COVID-19 vaccines, opting to continue evaluating data ...

A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.

Lawyers for both sides in the federal lawsuit, brought by six medical organizations, are trying to understand the ramifications of the judge’s decision.

Arexvy will now compete for market share with Pfizer’s Abrysvo and Moderna’s mRESVIA in this expanded, high-risk adult ...

Six years after early vaccine trials, the legacy of COVID-19 shots reflects science, public debate, and how perceptions ...